Gilde Healthcare Partners recruits new partners and opens new office in the US - Gilde Healthcare

Gilde Healthcare Partners recruits new partners and opens new office in the US

November 10, 2011

Utrecht, the Netherlands | Cambridge, USA – Gilde Healthcare Partners a €450 million ($600 million) venture and growth capital group based in Utrecht, Netherlands has announced the opening of its office in Cambridge, MA. The firm’s US investment activity is managed by Geoff Pardo who recently joined Gilde as Partner. Geoff has spent the last eleven years in a mix of venture capital and operating roles at Cardinal Partners, Spray Venture Partners and most recently as CEO of Facet Solutions, a spinal implant company that was sold to Globus Medical.  
In addition, Janke Dittmer joined Gilde Healthcare, in The Netherlands, as Partner. Janke has been senior director new business development and venture general manager at Philips Healthcare's corporate venturing unit. Prior to this he was a manager at McKinsey.

Earlier this week Gilde announced the first investment from Gilde Healthcare III in Inova Labs based in Austin, TX. Inova Labs has developed a novel, proprietary portable oxygen concentrator which allows for greater patient mobility for patients suffering from Chronic Obstructive Pulmonary Disease. The new round allows Inova to expand commercialization of its flagship product, LifeChO2ice.

About Gilde Healthcare Partners

Netherlands-based Gilde Healthcare Partners is a transatlantic venture and growth capital firm focused on private healthcare technology and service companies. It has over €450 million ($600 million) under management and is actively looking to lead new investments in therapeutics, diagnostics, medical devices and healthcare services. Gilde successfully builds healthcare businesses across Europe and US, investing up to €15 million ($20 million) in a single portfolio company. For a list of Gilde’s portfolio companies please visit the website at www.gildehealthcare.com.

Contact details

Gilde Healthcare Partners US Inc.
245 First Street, 18th floor
Cambridge, MA 02142
U.S.A.
Tel.: +1 617 395 9080

Gilde Healthcare Partners BV
Newtonlaan 91
3508 AB Utrecht
The Netherlands
Tel.: +31 30 219 2528

Gilde Healthcare company Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer

Biotech industry veteran to lead Tagworks as the company prepares to bring its novel platform and lead antibody-drug (ADC) conjugate program for solid tumors into the clinic in 2025 Founding CEO Marc Robillard, Ph.D., will...
October 1, 2024

Gilde Healthcare company Spire Health merges with Wellinks to form Industry Leader in Predictive Patient Care for Cardiopulmonary Health

Wellinks, the industry leader in virtual-led cardiopulmonary care, announced today it has merged with Spire Health in a non-cash transaction. The transaction merges Spire’s novel patient monitoring technology with Wellinks highly specialized virtual-led cardiopulmonary care model...
September 30, 2024

Gilde Healthcare company Big Health receives US FDA Clearance for DaylightRx

First FDA cleared non-drug treatment for generalized anxiety disorder. Clearance is the second FDA-clearance for Big Health. Big Health, a leading developer of digital mental health treatments, has been granted clearance by the U.S. Food...
September 5, 2024